Ono Pharmaceutical Co., Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
No of Months
12
12
12
12
12
12
Profit Before Tax
59,203.00
163,733.00
143,528.00
105,031.00
100,886.00
79,696.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
33,467.00
-28,761.00
3,784.00
-30,167.00
-10,983.00
5,787.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
82,459.00
110,660.00
159,610.00
61,829.00
73,977.00
74,157.00
Cash Flow from Investing Activities
-136,785.00
48,077.00
-100,259.00
6,038.00
-57,586.00
-10,234.00
Cash Flow from Financing Activities
94,299.00
-89,848.00
-32,484.00
-60,237.00
-24,754.00
-54,721.00
Net Cash Inflow / Outflow
38,425.00
70,005.00
27,022.00
8,066.00
-7,960.00
9,023.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
-1,548.00
1,116.00
155.00
436.00
403.00
-179.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in JPY Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Ono Pharmaceutical Co., Ltd.
Figures in Million
consolidated Cash Flow Results
Change(JPY)
Change(%)
Profit Before Tax
59203
200750
-1,41,547.00
-70.51%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
33467
5744
27,723.00
482.64%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
82459
195460
-1,13,001.00
-57.81%
Cash Flow from Investing Activities
-136785
-129069
-7,716.00
-5.98%
Cash Flow from Financing Activities
94299
-51919
1,46,218.00
281.63%
Net Cash Inflow / Outflow
38425
16705
21,720.00
130.02%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
-1548
2233
-3,781.00
-169.32%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Mar'25
YoY Growth in year ended Mar 2025 is -25.48% vs -30.67% in Mar 2024
Mar'25
Mar'24
Change(%)
Cash Flow from Operating Activities
82,459.00
1,10,660.00
-25.48%






